Compare YPF & GMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | YPF | GMED |
|---|---|---|
| Founded | 1977 | 2003 |
| Country | Argentina | United States |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 206.0B | 11.0B |
| IPO Year | 1995 | 2012 |
| Metric | YPF | GMED |
|---|---|---|
| Price | $54.68 | $74.54 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 14 |
| Target Price | $45.67 | ★ $100.42 |
| AVG Volume (30 Days) | 1.2M | ★ 1.2M |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 422.67 |
| EPS | N/A | ★ 2.00 |
| Revenue | N/A | ★ $2,938,931,000.00 |
| Revenue This Year | $14.39 | $11.13 |
| Revenue Next Year | N/A | $6.28 |
| P/E Ratio | ★ N/A | $37.08 |
| Revenue Growth | N/A | ★ 16.65 |
| 52 Week Low | $23.02 | $54.17 |
| 52 Week High | $57.87 | $101.40 |
| Indicator | YPF | GMED |
|---|---|---|
| Relative Strength Index (RSI) | 56.40 | 37.91 |
| Support Level | $48.64 | $74.10 |
| Resistance Level | $56.82 | $82.23 |
| Average True Range (ATR) | 1.84 | 2.02 |
| MACD | 0.10 | -0.44 |
| Stochastic Oscillator | 54.23 | 20.60 |
YPF SA is an Argentina-based integrated oil and gas company. The company operates through four business segments: Upstream, Midstream and Downstream, LNG and Integrated Gas, and New Energies. The Upstream segment focuses on the exploration and production of crude oil and natural gas. The Midstream and Downstream segment includes refining, transportation, and commercialization of crude oil, refined, and petrochemical products. The LNG and Integrated Gas segment is involved in natural gas transportation, processing, storage, and commercialization. The New Energies segment focuses on energy transition initiatives, including natural gas distribution, power generation, renewable energy, and related technology development. It generates majority of revenue from Midstream and Downstream segment.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.